Intravenous glutamine-dipeptide and early nasojejunal feeding in severe acute pancreatitis

A combination of intravenous glutamine-dipeptide and early nasojejunal nutrition in severe acute pancreatitis: a prospective randomized double-blind clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN60549685

Enrollment

Registered

2012-09-27

Start date

2008-09-04

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute pancreatitis Digestive System Acute pancreatitis

Interventions

The trial will involve about 60patients, admitted to the surgical department of Petz Aladar County Teaching Hospital, Gyor, Hungary. Participants will recieve the same treatment according to local gui

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients admitted with severe acute pancreatitis 2. Glasgow score at least 3 or CRP level over 150 mg/ml

Exclusion criteria

Exclusion criteria: 1. Age under 18 years 2. Pregnancy 3. Patients with complaints starting before the last 48 hours of admission 4. Death within 48 hours of admission

Design outcomes

Primary

Measure	Time frame
1. Rate of pancreas-specific infectious complications 2. Organ failures	—

Secondary

Measure	Time frame
1. Comparison of radiological and surgical interventions 2. Length of hospital stay 3. Mortality rate	—

Countries

Hungary

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026